SimSon Growth Intelligence

build

Make something SimSon does not currently list.

expand

Add to a product family SimSon already lists.

sell

Take coverage SimSon already has to market.

enter

Move into a segment or geography SimSon is adjacent to.

watch

Do nothing yet; re-check when the evidence changes.

ignore

Not worth SimSon's time on the current evidence.

GAP

A commercially relevant molecule or product appears absent from SimSon while demand or catalyst evidence exists.

LEAD

SimSon already has public catalogue coverage that the checked peer set does not visibly match.

DEPTH

SimSon demonstrates substantial observed public catalogue depth for the molecule.

TIMING

A dated catalyst is forcing analytical work now — a novel approval, an NDSRI limit, a loss of exclusivity or a generic filing wave.

ADJACENCY

SimSon has strong adjacent coverage and a small extension would complete an attractive family.

ACCESS

Public filings, trials or regulatory records expose identifiable organisations associated with the molecule. This is NOT a claim that any of them is a SimSon customer.

A shape is what the evidence exposes; an action is what the decision table does about it. The two are separate on purpose — several shapes can point at the same action, and the action is always chosen by a fixed rule rather than by judgement.